Recent research has found a link between mothers that take Depakote, an epilepsy drug, and metal retardation in toddlers. Children exposed to Depakote while still in the womb were twice as likely to test within the range associated with mental retardation at the ages of two to three years old.
The study responsible for the findings continues to track the children through the age of six. Although results may not prove fully clear until then, research did find toddlers exposed to Depakote scored significantly lower on I.Q. tests measuring standard intelligence than children that did not come into contact with the drug.
Depakote is an anticonvulsant medication that has been identified in previous studies as a possible cause of birth defects and mental deficits in newborns. Of the other drugs in its class, Depakote often appears as the most dangerous due to such side effects.